Pre-transplant optimization by Molecular Adsorbent Recirculating System in patients with severely decompensated chronic liver disease

Indian Journal of Gastroenterology

Volumn 26, Issue 3, 2007, Pages 110-112

  Wagholikar, Gajanan D ^a   Lee, Kang Hoe ^a   Pandey, Durgatosh ^a   Leong, See Odd ^a   Singh, Ranjodh ^a   Tan, Kai Chah ^a  

^a GLENEAGLES HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BILIRUBIN; CREATININE;

ADULT; ALBUMIN DIALYSIS; AMMONIA BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PREOPERATIVE TREATMENT;

ADULT; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34548065536     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Yoo HY, Thuluvath PJ. Short-term post-liver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int 2005;25:536-41.
2. Testa G, Malago M, Nadalin S, Hertl M, Lang H, Frilling A, et al. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl 2002;8:340-6.
3. Lee KH, Wendon J, Lee M, Da Costa M, Lim SG, Tan KC. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin. Liver Transpl 2002;8:591-3.
4. Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol 2005;100:468-75.
5. Hassanein T, Tofteng F, Brown RS Jr, McGuire BM, Lynch P, Mehta R, et al. Efficacy of albumin dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephalopathy: a prospective, controlled, randomized, multicenter trial (Abstract). Hepatology 2004;40(Suppl 1):726A.
6. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
7. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005;11:594-605.
8. Trey C, Burns DG, Saunders SJ. Treatment of hepatic coma by exchange blood transfusions. N Engl J Med 1966;274:473-81.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
10. Chiu A, Chan LM, Fan ST. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 2006;26:695-702.
11. Brown RS Jr. MARS preconditioning for living donor liver transplantation: panacea or placebo? Liver Int 2005;25:692-5.
12. Choi JY, Bae SH, Yoon SK, Cho SH, Yang JM, Han JY, et al. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study. Liver Int 2005;25:740-5.